Krystyna Caratachea
Family · Newport News, VANPI 1811951585
Payments from drug & device makers
Across 136 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$576
- Biohaven Pharmaceuticals, Inc.$322
- Takeda Pharmaceuticals U.S.A., Inc.$239
- AstraZeneca$183
- Lilly USA, LLC$170
- Novo Nordisk$142
- plus $751 from 17 others
What the payments were for
- Food & beverage$2,383100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $576 |
| Biohaven Pharmaceuticals, Inc. | 9 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $239 |
| AstraZeneca | 11 | $183 |
| Lilly USA, LLC | 11 | $170 |
| Novo Nordisk | 8 | $142 |
| Boehringer Ingelheim | 6 | $124 |
| Clarus Therapeutics Inc. | 6 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Pfizer | 3 | $62 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| GSK | 2 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Mylan Specialty L.p. | 2 | $28 |
| Amgen | 2 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Scynexis, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$111
How this compares
$2,383 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $273 |
| Levothyroxine Sodium | 15 | $151 |
| Atorvastatin Calcium | 19 | $99 |
| Lisinopril | 13 | $81 |
| Hydrochlorothiazide | 11 | $71 |
| Amlodipine Besylate | 21 | $59 |
| Simvastatin | 11 | $42 |
| Furosemide | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other family in Newport News
- Rosemarie McFatherNewport News$13K
- Sabrina BrownNewport News$11K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.